RaySearch Laboratories AB has announced its expanded collaboration with proton therapy provider P-Cure, aiming at enhancing the workflow efficiency of P-Cure’s proton therapy system through integration with RaySearch’s systems RayStation and RayCare. Image courtesy: P-Cure
October 4, 2023 — RaySearch Laboratories AB has announced its expanded collaboration with P-Cure, aiming at enhancing the workflow efficiency of P-Cure’s proton therapy system through integration with RaySearch’s systems RayStation and RayCare.
The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment, according to an Oct. 1 statement released by Raysearch. It further noted that the P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East, to treat CNS, head and neck, thoracic and pancreatic malignancies.
The partnership is an organic continuation of the existing relationship between the companies that has already resulted in integration of RayStation in a study conducted at the P-Cure clinical development center, operated clinically by Hadassah Medical Center. According to the written statement on the collaboration, the partnership will enable users of the P-Cure proton therapy system to also utilize the automation and workflow support provided by RayCare, as well as the features for adaptive radiation therapy in the RaySearch systems.
P-Cure Ltd. develops and supplies a compact proton therapy solution for the targeted treatment of cancer with radiation. Founded in 2007, P-Cure has developed a comprehensive patient centric proton therapy solution with clinical benefits and financial advantages. The Israel-based company notes that by significantly reducing the capital and operating costs, P-Cure expands the availability of proton therapy to all cancer care institutions and new facility developers worldwide.
RaySearch Laboratories AB (publ) is a Stockholm, Sweden-based medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system (TPS) and the oncology information system (OIS) RayCare, which it notes is subject to regulatory clearance in some markets. The company reports that RaySearch's software has been sold to over 900 clinics in more than 40 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm.
More information: www.raysearchlabs.com